Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 08/02/12 | 8-K | Current report filing |
|
5 | |
| 07/17/12 | 3 | Initial statement of beneficial ownership of securities |
|
3 | |
| 07/17/12 | 4 | Statement of changes in beneficial ownership of securities |
|
4 | |
| 07/16/12 | 3 | Initial statement of beneficial ownership of securities |
|
4 | |
| 07/16/12 | SC 13G/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
13 | |
| 07/12/12 | SC 13G | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
13 | |
| 07/12/12 | 8-K | Current report filing |
|
5 | |
| 06/27/12 | 8-K | Current report filing |
|
44 | |
| 06/21/12 | 424B4 | Prospectus filed pursuant to Rule 424(b)(4) |
|
94 | |
| 06/21/12 | 8-K | Current report filing |
|
6 |
